Doctor urges limited use of Boston Scientific’s new device

CHICAGO (Reuters) – Boston Scientific Corp’s new leadless implantable heart defibrillator, hailed by some as a breakthrough, should be used on a limited basis until more data are collected, a prominent cardiologist wrote in an editorial of a top medical journal. Leads, or wires that carry electrical pulses from the defibrillator – which is implanted in the chest – to the heart have always been the weak link in these systems, used to treat irregular heart beats. All of the device makers have had problems at one time or another with leads. …